 |
The Journal of Neuroscience, July 2, 2003, 23(13):5645-5649
Previous Article | Next Article 
Presenilin Redistribution Associated with Aberrant Cholesterol Transport Enhances -Amyloid Production In Vivo
Mark Burns,1,2
Kate Gaynor,1
Vicki Olm,1
Marc Mercken,3
John LaFrancois,1
Lili Wang,1
Paul M. Mathews,1,2
Wendy Noble,1
Yasuji Matsuoka,1,2 and
Karen Duff1,2
1Center for Dementia Research, Nathan S. Kline
Institute, Orangeburg, New York 10962, 2Department of
Psychiatry, New York University School of Medicine, New York, New York 10016,
and 3Johnson and Johnson Pharmaceutical Research and
Development, Janssen Pharmaceutica, B-2340 Beerse, Belgium
Epidemiology, in vitro, and in vivo studies strongly
implicate a role for cholesterol in the pathogenesis of Alzheimer's disease
(AD). We have examined the impact of aberrant intracellular cholesterol
transport on the processing of the amyloid precursor protein (APP) in a mouse
model of Niemann-Pick type C (NPC) disease. In the NPC mouse brain,
cholesterol accumulates in late endosomes/lysosomes. This was associated with
the accumulation of -C-terminal fragments (CTFs) of APP, but the level
of -secretase and its activity were not affected. -Secretase
activity and secreted APP generation were also not affected, suggesting
CTFs increased because of decreased clearance. The level of presenilin-1
(PS-1) was unchanged, but -secretase activity was greatly enhanced,
which correlated with an increase in A 40 and A 42 levels. These
events were associated with abnormal distribution of PS-1 in the endosomal
system. Our results show that aberrant cholesterol trafficking is associated
with the potentiation of APP processing components in vivo, leading
to an overall increase in A levels.
Key words: amyloid; cholesterol; Niemann-Pick; NPC; -CTF; -secretase; presenilin; Rab 5; endosome
Received Dec. 3, 2002;
revised Apr. 24, 2003;
accepted Apr. 24, 2003.
This article has been cited by other articles:

|
 |

|
 |
 
P. Osenkowski, W. Ye, R. Wang, M. S. Wolfe, and D. J. Selkoe
Direct and Potent Regulation of {gamma}-Secretase by Its Lipid Microenvironment
J. Biol. Chem.,
August 15, 2008;
283(33):
22529 - 22540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Burgess, P. F. Parkinson, M. M. Racke, V. Hirsch-Reinshagen, J. Fan, C. Wong, S. Stukas, L. Theroux, J. Y. Chan, J. Donkin, et al.
ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo
J. Lipid Res.,
June 1, 2008;
49(6):
1254 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Muhammad, I. Flores, H. Zhang, R. Yu, A. Staniszewski, E. Planel, M. Herman, L. Ho, R. Kreber, L. S. Honig, et al.
Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and A{beta} accumulation
PNAS,
May 20, 2008;
105(20):
7327 - 7332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, O. Ghribi, and J. D. Geiger
Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2008;
294(3):
R829 - R835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W. H. Yu, J. A. Luchsinger, B. Wadzinski, K. E. Duff, et al.
Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms
J. Neurosci.,
December 12, 2007;
27(50):
13635 - 13648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Liao, Y. Yao, J. Liu, Z. Yu, S. Cheung, A. Xie, X. Liang, and X. Bi
Cholesterol Accumulation Is Associated with Lysosomal Dysfunction and Autophagic Stress in Npc1 / Mouse Brain
Am. J. Pathol.,
September 1, 2007;
171(3):
962 - 975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Tansley, B. L. Burgess, M. T. Bryan, Y. Su, V. Hirsch-Reinshagen, J. Pearce, J. Y. Chan, A. Wilkinson, J. Evans, K. E. Naus, et al.
The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of {beta}-amyloid precursor protein
J. Lipid Res.,
May 1, 2007;
48(5):
1022 - 1034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Planel, K. E. G. Richter, C. E. Nolan, J. E. Finley, L. Liu, Y. Wen, P. Krishnamurthy, M. Herman, L. Wang, J. B. Schachter, et al.
Anesthesia Leads to Tau Hyperphosphorylation through Inhibition of Phosphatase Activity by Hypothermia
J. Neurosci.,
March 21, 2007;
27(12):
3090 - 3097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Qin, T. Yang, L. Ho, Z. Zhao, J. Wang, L. Chen, W. Zhao, M. Thiyagarajan, D. MacGrogan, J. T. Rodgers, et al.
Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction
J. Biol. Chem.,
August 4, 2006;
281(31):
21745 - 21754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Tate and P. M. Mathews
Targeting the Role of the Endosome in the Pathophysiology of Alzheimer's Disease: A Strategy for Treatment
Sci. Aging Knowl. Environ.,
June 28, 2006;
2006(10):
re2 - re2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Walterfang, M. Fietz, M. Fahey, D. Sullivan, P. Leane, D. I. Lubman, and D. Velakoulis
The Neuropsychiatry of Niemann-Pick Type C Disease in Adulthood
J Neuropsychiatry Clin Neurosci,
May 1, 2006;
18(2):
158 - 170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-R. Yang, S.-J. Kim, K.-H. Byun, B. Hutchinson, B.-H. Lee, M. Michikawa, Y.-S. Lee, and K.-S. Kang
NPC1 Gene Deficiency Leads to Lack of Neural Stem Cell Self-Renewal and Abnormal Differentiation Through Activation of p38 Mitogen-Activated Protein Kinase Signaling
Stem Cells,
February 1, 2006;
24(2):
292 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Cole, A. Grudzien, I. O. Manhart, B. L. Kelly, H. Oakley, and R. Vassar
Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism
J. Biol. Chem.,
May 13, 2005;
280(19):
18755 - 18770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Nelson and D. L. Alkon
Oxidation of Cholesterol by Amyloid Precursor Protein and {beta}-Amyloid Peptide
J. Biol. Chem.,
February 25, 2005;
280(8):
7377 - 7387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Liu, L. Yang, K. Conde-Knape, D. Beher, M. S. Shearman, and N. S. Shachter
Fatty acids increase presenilin-1 levels and {gamma}-secretase activity in PSwt-1 cells
J. Lipid Res.,
December 1, 2004;
45(12):
2368 - 2376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Vetrivel, H. Cheng, W. Lin, T. Sakurai, T. Li, N. Nukina, P. C. Wong, H. Xu, and G. Thinakaran
Association of {gamma}-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes
J. Biol. Chem.,
October 22, 2004;
279(43):
44945 - 44954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Brown III, C. Theisler, S. Silberman, D. Magnuson, N. Gottardi-Littell, J. M. Lee, D. Yager, J. Crowley, K. Sambamurti, M. M. Rahman, et al.
Differential Expression of Cholesterol Hydroxylases in Alzheimer's Disease
J. Biol. Chem.,
August 13, 2004;
279(33):
34674 - 34681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Nixon
Niemann-Pick Type C Disease and Alzheimer's Disease: The APP-Endosome Connection Fattens Up
Am. J. Pathol.,
March 1, 2004;
164(3):
757 - 761.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|